Credit Agricole’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.1M Sell
74,000
-8,500
-10% -$8.62M 0.18% 101
2025
Q4
$88.7M Buy
82,500
+3,500
+4% +$3.35M 0.2% 86
2025
Q3
$60.3M Buy
+79,000
New +$58.8M 0.16% 109
2025
Q1
$26.8M Buy
32,500
+8,000
+33% +$6.66M 0.08% 183
2024
Q4
$18.9M Buy
24,500
+7,500
+44% +$6.21M 0.06% 244
2024
Q3
$15.1M Buy
17,000
+3,500
+26% +$3.15M 0.06% 207
2024
Q2
$12.2M Hold
13,500
0.07% 204
2024
Q1
$10.1M Buy
+13,500
New +$9.61M 0.11% 152
2023
Q2
Sell
-12,500
Closed -$4.29M 716
2023
Q1
$4.29M Buy
+12,500
New +$4.22M 0.09% 171

Other funds holding LLY

Credit Agricole's LLY Position: Q1 2026 in Review

Credit Agricole reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $35.9M and leaving 275,920 shares worth $254M. The position accounts for 0.67% of the portfolio, ranked #22.

Credit Agricole first reported a position in LLY in Q3 2013 and has held it in 47 quarters since. The position peaked at $335M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Credit Agricole held 275,920 shares of Eli Lilly worth $254M as of Q1 2026.
  • Credit Agricole sold 35,455 Eli Lilly shares in Q1 2026, an estimated $35.9M.
  • Eli Lilly made up 0.67% of Credit Agricole's portfolio in Q1 2026, its #22 holding.
  • Credit Agricole first reported a position in Eli Lilly in Q3 2013 and has held it in 47 quarters since.
  • Credit Agricole's Eli Lilly position peaked at $335M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.